MetLife (MET) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Adjusted earnings rose 18% year-over-year to $1.6 billion ($2.42 per share), with EPS up 23%, driven by broad-based growth, disciplined capital management, and the PineBridge acquisition.
Net income available to common shareholders increased to $1.1 billion ($1.74 per share), up from $879 million, reflecting higher adjusted earnings and favorable market risk benefit remeasurement.
All operating business segments posted higher adjusted earnings, with strong top-line growth across regions and products.
The New Frontier strategy focuses on accelerating execution, delivering on ambitious financial commitments, and expanding in high-growth international markets.
Over $1.1 billion was returned to shareholders through share repurchases and dividends, with a 4.4% dividend increase.
Financial highlights
Net income was $1.1 billion ($1.74 per share); adjusted EPS was $2.42, up 23% year-over-year.
Total revenues for Q1 2026 were $19.1 billion, up from $18.6 billion; net investment income increased to $5.4 billion, with variable investment income up 58% to $518 million.
Adjusted book value per share was $57.41, up from $55.01 in Q1 2025.
Direct expense ratio improved to 11.9%, better than the 12.1% full-year target.
Cash and liquid assets at holding companies totaled $3.9 billion at quarter end.
Outlook and guidance
Confident in delivering on full-year and long-term financial commitments under the New Frontier strategy, targeting double-digit adjusted EPS growth, 15–17% adjusted ROE, and over $25 billion in free cash flow for 2024–2029.
RIS full-year adjusted earnings expected to remain within the $1.6 billion–$1.8 billion range.
Core spreads in RIS expected to remain stable or slightly improve in Q2, with total spreads tracking to full-year guidance.
EMEA earnings expected to trend toward the upper end of the $90 million–$100 million quarterly run rate.
Management continues to monitor global economic and market volatility, including inflation, interest rates, and geopolitical risks.
Latest events from MetLife
- Shareholders will vote on directors, executive pay, and auditor ratification at the annual meeting.MET
Proxy filing29 Apr 2026 - Strong financial results, board refreshment, and robust pay-for-performance drive momentum.MET
Proxy filing29 Apr 2026 - New Frontier strategy accelerates growth, efficiency, and global expansion.MET
Bank of America Financial Services Conference 202611 Apr 2026 - Scale, technology, and disciplined growth drive strong earnings and market leadership.MET
47th Annual Raymond James Institutional Investor Conference4 Mar 2026 - Adjusted EPS up 10%, 16% ROE, and record AUM after major acquisition.MET
Q4 20255 Feb 2026 - Board, compensation, and auditor proposals passed; racial equity audit proposal rejected.MET
AGM 20243 Feb 2026 - Net income surged 146% with adjusted earnings up 9% and record Group Benefits results.MET
Q2 20242 Feb 2026 - Surpassed strategic goals and set sights on accelerated growth with the New Frontier plan.MET
2024 KBW Insurance Conference22 Jan 2026 - Net income jumped to $1.3B, but adjusted earnings declined 8% year-over-year.MET
Q3 202417 Jan 2026